Emily Zielinski-Gutierrez

Emily Zielinski-Gutierrez

Auto-generated profile, based on publicly available information

Emily Zielinski-Gutierrez

Centers for Disease Control and Prevention—Central America, Guatemala City, Guatemala

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Max Moreno-MadriñánMax Moreno-Madriñán
Max Moreno-Madriñán
WCWilliam L. Crosson
William L. Crosson
LELars Eisen
Lars Eisen
SESue M. Estes
Sue M. Estes
MJMaurice G Estes Jr.
Maurice G Estes Jr.
EZEmily Zielinski-Gutierrez
Emily Zielinski-Gutierrez
Using a geographic transect in Central Mexico, with an elevation/climate gradient, but uniformity in socio-economic conditions among study sites, this study evaluates the applicability of three widely-used remote sensing (RS) products to link weather conditions with the local abundance of the dengue virus mosquito vector, Aedes aegypti (Ae. aegypti). Field-derived entomological measures included estimates for the percentage of premises with the presence of Ae. aegypti pupae and the abundance of Ae. aegypti pupae per premises. Data on mosquito abundance from field surveys were matched with RS data and analyzed for correlation. Daily daytime and nighttime land surface temperature (LST) values were obtained from Moderate Resolution Imaging Spectroradiometer (MODIS)/Aqua cloud-free images within the four weeks preceding the field survey. Tropical Rainfall Measuring Mission (TRMM)-estimated rainfall accumulation was calculated for the four weeks preceding the field survey. Elevation was estimated through a digital elevation model (DEM). Strong correlations were found between mosquito abundance and RS-derived night LST, elevation and rainfall along the elevation/climate gradient. These findings show that RS data can be used to predict Ae. aegypti abundance, but further studies are needed to define the climatic and socio-economic conditions under which the correlations observed herein can be assumed to apply.
1

21 October 2019 in BMC Public Health
Verified
Journal Article
Open access
PDF file
GZGarazi Zulaika
Garazi Zulaika
DKDaniel Kwaro
Daniel Kwaro
ENElizabeth Nyothach
Elizabeth Nyothach
DWDuolao Wang
Duolao Wang
EZEmily Zielinski-Gutierrez
Emily Zielinski-Gutierrez
PPPenelope Phillips-Howard
Penelope Phillips-Howard
Background: Adolescent girls in sub-Saharan Africa are disproportionally vulnerable to sexual and reproductive health (SRH) harms. In western Kenya, where unprotected transactional sex is common, young females face higher rates of school dropout, often due to pregnancy, and sexually transmitted infections (STIs), including HIV. Staying in school has shown to protect girls against early marriage, teen pregnancy, and HIV infection. This study evaluates the impact of menstrual cups and cash transfer interventions on a composite of deleterious outcomes (HIV, HSV-2, and school dropout) when given to secondary schoolgirls in western Kenya, with the aim to inform evidence-based policy to improve girls’ health, school equity, and life-chances. Methods: Single site, 4-arm, cluster randomised controlled superiority trial. Secondary schools are the unit of randomisation, with schoolgirls as the unit of measurement. Schools will be randomised into one of four intervention arms using a 1:1:1:1 ratio and block randomisation: (1) menstrual cup arm; (2) cash transfer arm, (3) cups and cash combined intervention arm, or (4) control arm. National and county agreement, and school level consent will be obtained prior to recruitment of schools, with parent consent and girls’ assent obtained for participant enrolment. Participants will be trained on safe use of interventions, with all arms receiving puberty and hygiene education. Annually, the state of latrines, water availability, water treatment, handwashing units and soap in schools will be measured. The primary endpoint is a composite of incident HIV, HSV-2, and all-cause school dropout, after 3 years follow-up. School dropout will be monitored each term via school registers and confirmed through home visits. HIV and HSV-2 incident infections and risk factors will be measured at baseline, mid-line and end-line. Intention to treat analysis will be conducted among all enrolled participants. Focus group discussions will provide contextual information on uptake of interventions. Monitoring for safety will occur throughout. Discussion: If proved safe and effective, the interventions offer a potential contribution toward girls’ schooling, health, and equity in low- and middle-income countries. Trial registration: ClinicalTrials.gov NCT03051789, 15th February 2017.

1 July 2012 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Closed access
PDF file
CGCarmen L. Pérez Guerra
Carmen L. Pérez Guerra
RRRosa Rodríguez-Acosta
Rosa Rodríguez-Acosta
ESEunice Soto-Gómez
Eunice Soto-Gómez
EZEmily Zielinski-Gutierrez
Emily Zielinski-Gutierrez
MPMarisol Peña-Orellana
Marisol Peña-Orellana
GDGustavo Dayan
Gustavo Dayan
Dengue, endemic in Puerto Rico, is a major public health problem. Vaccines are thought the best means to prevent dengue because vector control alone has been largely ineffective. We implemented qualitative studies in 2006 and 2010 to determine the acceptability of conducting placebo-controlled dengue vaccine efficacy trials in Puerto Rican children. Key informant interviews and focus groups with parents and children were conducted in municipalities with high dengue incidence. We used structured open-ended questions to determine motivators and attitudes regarding vaccine trial participation. Knowledge about dengue risk and prevention, and knowledge, attitudes, and beliefs regarding vaccines and vaccine trials were assessed. Using grounded theory, we conducted content analysis and established categories and sub-categories of participant responses. All participants were knowledgeable about dengue prevention and perceived children as most affected age groups. Participants were aware of vaccines benefits and they thought a vaccine could prevent dengue. However, most would not allow their children to participate in a placebo-controlled vaccine trial. Barriers included lack of trust in new vaccines and vaccine trial procedures; fear of developing dengue or side effects from the vaccine and lack of information about candidate dengue vaccines. Participants thought information, including results of previous trials might overcome barriers to participation. Motivators for participation were altruism, protection from dengue, free medical attention, and compensation for transportation and participation. Parents would consider children participation if accurate vaccine trial information is provided.

13 December 2018 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
AWAnthony K. Waruru
Anthony K. Waruru
1N1 Natukunda
1 Natukunda
LNLilly Nyagah
Lilly Nyagah
TKTimothy A Kellogg
Timothy A Kellogg
EZEmily Zielinski-Gutierrez
Emily Zielinski-Gutierrez
PYPeter W Young
Peter W Young
A multidisciplinary journal that focuses on public health and technology, public health informatics, mass media campaigns, surveillance, and innovation in public health practice and research. Also dedicated to rapid open data sharing during epidemics.

14 November 2022 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
PDF file
Kristy MurrayKristy Murray
Kristy Murray
MSMiguel A. Saldaña
Miguel A. Saldaña
SGSarah Gunter
Sarah Gunter
RMRussell Manzanero
Russell Manzanero
EZEmily Zielinski-Gutierrez
Emily Zielinski-Gutierrez
GMGerhaldine Beatriz Morazan
Gerhaldine Beatriz Morazan
In January 2020, we instituted acute febrile illness surveillance in 11 hospitals and clinics across Belize. Within 3 months, we diagnosed an acute case of Chagas disease by polymerase chain reaction in a 7-year-old child in the northern part of the country. Phylogenetic analyses of the parasite from the acute blood specimen revealed a multiclonal Trypanosoma cruzi infection, including parasites from the TcII (25.0% of haplotypes), TcIV (2.5% of haplotypes), and TcV (72.5% of haplotypes) discrete typing units. The family reported no history of travel, and three Triatoma species vectors were found within the home. The child’s mother was seronegative for antibodies to T. cruzi, ruling out congenital transmission. Convalescent blood samples documented seroconversion and confirmed acute infection. The child was successfully treated with nifurtimox. This is the first known diagnosed case of acute Chagas infection in Belize, highlighting the need for further investigation and public health prevention measures.

Verified
Journal Article
Open access
PDF file
BMBeatris Mario Martin
Beatris Mario Martin
ARAngela Cadavid Restrepo
Angela Cadavid Restrepo
HMHelen J Mayfield
Helen J Mayfield
CPCecilia Then Paulino
Cecilia Then Paulino
MAMicheal De St Aubin
Micheal De St Aubin
Colleen LauColleen Lau
Colleen Lau
Incidence of COVID-19 has been associated with sociodemographic factors. We investigated variations in SARS-CoV-2 seroprevalence at sub-national levels in the Dominican Republic and assessed potential factors influencing variation in regional-level seroprevalence. Data were collected in a three-stage cross-sectional national serosurvey from June to October 2021. Seroprevalence of antibodies against the SARS-CoV-2 spike protein (anti-S) was estimated and adjusted for selection probability, age, and sex. Multilevel logistic regression was used to estimate the effect of covariates on seropositivity for anti-S and correlates of 80% protection (PT80) against symptomatic infection for the ancestral and Delta strains. A total of 6683 participants from 134 clusters in all 10 regions were enrolled. Anti-S, PT80 for the ancestral and Delta strains odds ratio varied across regions, Enriquillo presented significant higher odds for all outcomes compared with Yuma. Compared to being unvaccinated, receiving ≥2 doses of COVID-19 vaccine was associated with a significantly higher odds of anti-S positivity (OR 85.94, [10.95–674.33]) and PT80 for the ancestral (OR 4.78, [2.15–10.62]) and Delta strains (OR 3.08, [1.57–9.65]) nationally and also for each region. Our results can help inform regional-level public health response, such as strategies to increase vaccination coverage in areas with low population immunity against currently circulating strains.